Skip to main content
Accessibility|Contact|Privacy|Terms|Cookies

Drinking Coffee Improves Hepatitis C Treatment Response

  • Published: 2011-06-09 (Revised/Updated 2015-03-31) : Author: American Gastroenterological Association
  • Synopsis: Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment.

Quote: "Coffee intake has been associated with a lower level of liver enzymes, reduced progression of chronic liver disease and reduced incidence of liver cancer."

Main Document

Coffee intake has been associated with a lower level of liver enzymes.

Advanced hepatitis C patients with chronic liver disease may benefit from drinking coffee during treatment, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

Patients who received peginterferon plus ribavirin treatment and who drank three or more cups of coffee per day were two times more likely to respond to treatment than non-drinkers.

"Coffee intake has been associated with a lower level of liver enzymes, reduced progression of chronic liver disease and reduced incidence of liver cancer," said Neal Freedman, PhD, MPH, of the National Cancer Institute and lead author of this study. "Although we observed an independent association between coffee intake and virologic response to treatment, this association needs replication in other studies."

Among non-drinkers, 46 percent had an early virologic response;

26 percent had no detectable serum hepatitis C virus (HCV) ribonucleic acid at week 20;

22 percent had no detectable serum at week 48;

11 percent had a sustained virologic response.

In contrast, the corresponding proportions for those who drank three or more cups of coffee per day were 73 percent, 52 percent, 49 percent and 26 percent, respectively.

Approximately 70 to 80 percent of individuals exposed to HCV become chronically infected. Worldwide, these individuals are estimated to number between 130 and 170 million. Higher coffee consumption has been associated with slower progression of pre-existing liver disease and lower risk of liver cancer. However, the relationship with response to anti-HCV treatment had not been previously evaluated. Treatment with peginterferon and ribavirin resolves chronic hepatitis C in about half of patients. It is unknown whether coffee will improve response with the addition of new drugs that were recently approved for use in the U.S.

Because patients in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial also had previously failed interferon therapy, it is not clear whether the results can be generalized to other patient populations. Future studies among patients with less advanced disease, those who are treated to prior therapy, or who are being treated with newer antiviral agents are needed.

For more information on hepatitis, please read the AGA brochure "Understanding Hepatitis" at www.gastro.org/patient-center/digestive-conditions/hepatitis or visit the National Institute of Diabetes and Digestive and Kidney Diseases at digestive.niddk.nih.gov/ddiseases/pubs/hepc_ez

About the AGA Institute -The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org

About Gastroenterology -Gastroenterology, the official journal of the AGA Institute, is the most prominent scientific journal in the specialty and is in the top 1 percent of indexed medical journals internationally. The journal publishes clinical and basic science studies of all aspects of the digestive system, including the liver and pancreas, as well as nutrition. The journal is abstracted and indexed in Biological Abstracts, Current Awareness in Biological Sciences, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Nutrition Abstracts and Science Citation Index. For more information, visit www.gastrojournal.org

Discussion

• Discuss this article on our FaceBook Page.

Similar Topics

1 : Diabetes and Hepatitis B Risk : GSK.
2 : Hepatitis Transmission Risk in Nail Salons and Barbershops : American College of Gastroenterology.
3 : Drinking Coffee Improves Hepatitis C Treatment Response : American Gastroenterological Association.
4 : FDA Approves Victrelis for Hepatitis C : U.S. Food and Drug Administration.
5 : Millions of Americans Are Living with Hidden Epidemics of Hepatitis B and C : Trust for America's Health.
From our Hepatitis section - Full List (16 Items)


Submit disability news, coming events, as well as assistive technology product news and reviews.


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be, and information on blood group types/compatibility.





1 : Help Your Child in School by Adding Language to The Math
2 : 50% of Retirees Saw Little or No COLA Increase in Net 2018 Social Security Benefits
3 : Turnstone Endeavor Games Concludes with National Records Broken
4 : Spinning in Circles and Learning From Myself by Tsara Shelton
5 : St. Louis HELP Medical Equipment Donation Drive Generates Record-Breaking Results
6 : People Who Snore Suffer from Palate Nerve and Muscle Damage
7 : How Our Ancestors with Autistic Traits Led a Revolution in Ice Age Art
8 : Housing and Disabled People: Britains Hidden Crisis


Disclaimer: This site does not employ and is not overseen by medical professionals. Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.

Reporting Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.

© 2004 - 2018 Disabled World™